Bio-Rad Posts 3 Percent Revenue Growth for Q2 | GenomeWeb

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Tuesday that its second quarter revenues increased 3 percent year over year, due in part to its January acquisition of AbD Serotec.

The Hercules, Calif.-based firm brought in total revenues of $525.3 million for the three months ended June 30, compared to $$510.4 million for the second quarter of 2012. It fell short of the consensus Wall Street estimate of $532.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.